Shuttle Pharmaceuticals Holdings (SHPH) Share-based Compensation (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Share-based Compensation of $1684.0 in Q1 2026, up 100.23% quarter-over-quarter from -$717895.0 in Q4 2025, and down 99.22% on a YoY basis from $216941.0 in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Share-based Compensation (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Share-based Compensation history runs 6 years deep, the most recent figure standing at $1684.0 for Q1 2026.
- In Q1 2026, Share-based Compensation fell 99.22% year-over-year to $1684.0; the TTM figure through Mar 2026 stood at -$535040.0 (down 246.49% YoY), while the FY2025 annual figure was $322.0, down 99.88% from the prior year.
- Share-based Compensation was $1684.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from -$717895.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $400000.0 in Q3 2023 to a low of -$717895.0 in Q4 2025.
- Historically, Share-based Compensation has averaged $57296.9 across 5 years, with a median of $71162.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Share-based Compensation surged 1590.12% in 2023, then plunged 2353.42% in 2025.
- A 5-year view of Share-based Compensation shows it stood at -$119186.0 in 2022, then jumped by 172.59% to $86522.0 in 2023, then tumbled by 63.18% to $31858.0 in 2024, then slumped by 2353.42% to -$717895.0 in 2025, then surged by 100.23% to $1684.0 in 2026.
- The last three Share-based Compensation figures came in at $1684.0 (Q1 2026), -$717895.0 (Q4 2025), and $134318.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 36.86 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.04 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 2.17 Mn | 1.11 Mn | - | 1,684.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,684.00 |
| Mar 31, 2026 | 1,684.00 |
| Dec 31, 2025 | -717,895.00 |
| Dec 31, 2025 | -717,895.00 |
| Sep 30, 2025 | 134,318.00 |
| Sep 30, 2025 | 134,318.00 |
| Jun 30, 2025 | 46,853.00 |
| Jun 30, 2025 | 46,853.00 |
| Mar 31, 2025 | 216,941.00 |
| Mar 31, 2025 | 216,941.00 |
| Dec 31, 2024 | 31,858.00 |
| Dec 31, 2024 | 31,858.00 |
| Sep 30, 2024 | 45,275.00 |
| Sep 30, 2024 | 45,275.00 |
| Jun 30, 2024 | 71,162.00 |
| Jun 30, 2024 | 71,162.00 |
| Mar 31, 2024 | 111,449.00 |
| Mar 31, 2024 | 111,449.00 |
| Dec 31, 2023 | 86,522.00 |
| Dec 31, 2023 | 86,522.00 |